rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2008-9-12
|
pubmed:abstractText |
Clostridium difficile-associated disease (CDAD) is responsible for increased morbidity and a substantial economic burden. Incidences of CDAD, including those with a severe course of illness, have been increasing rapidly.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1559-6834
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
823-8
|
pubmed:meshHeading |
pubmed-meshheading:18643746-Clostridium difficile,
pubmed-meshheading:18643746-Cohort Studies,
pubmed-meshheading:18643746-Enterocolitis, Pseudomembranous,
pubmed-meshheading:18643746-Female,
pubmed-meshheading:18643746-Hospital Costs,
pubmed-meshheading:18643746-Humans,
pubmed-meshheading:18643746-Incidence,
pubmed-meshheading:18643746-Length of Stay,
pubmed-meshheading:18643746-Male,
pubmed-meshheading:18643746-Middle Aged
|
pubmed:year |
2008
|
pubmed:articleTitle |
Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population.
|
pubmed:affiliation |
Johns Hopkins Medical Institutes, Baltimore, Maryland, USA. xsong@cnmc.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|